5-[(2,4-dimethoxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 99988-44-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-[(2,4-dimethoxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
• 英文别名: 5-(2,4-Dimethoxy-benzylidene)-rhodanine；5-(2,4-dimethoxybenzylidene)-2-thioxothiazolidin-4-one；5-(2,4-Dimethoxy-benzyliden)-2-thioxo-thiazolidin-4-on
• CAS: 99988-44-0
• 化学式: C₁₂H₁₁NO₃S₂
• 分子量: 281.356
• InChiKey: AXWRYCWHNVYLQW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  105
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-[(2,4-dimethoxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one 在 sodium sulfide 、 sodium hydroxide 作用下， 生成 (Z)-3-(2,4-二甲氧基苯基)-2-(羟基亚氨基)丙酸
  参考文献：
  名称：

  Synthesis of Coumestrol, 3,9-Dihydroxy-6H-benzofuro [3,2-c] [1] benzopyran-6-one¹

  摘要：

  DOI：

  10.1021/ja01549a067
• 作为产物：
  描述：

  罗丹宁 、 2,4-二甲氧基苯甲醛 在 ammonium acetate 作用下， 以 甲苯 为溶剂， 反应 3.0h， 以82.84%的产率得到5-[(2,4-dimethoxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
  参考文献：
  名称：

  通过片段筛选鉴定新的锌结合化学型

  摘要：

  据报道，通过筛选无偏片段文库发现了一种新的锌结合化学型。使用天然质谱和表面等离子体共振的正交片段筛选方法，发现3-未取代的2,4-恶唑烷二酮片段对锌金属酶碳酸酐酶II（CA II）的微摩尔结合亲和力低。这种亲和力接近片段大小的伯苯磺酰胺的亲和力，这是大多数CA II抑制剂中发现的经典锌结合基团。蛋白质X射线晶体学确定，通过酸性环氮与CA II活性位点锌的相互作用以及恶唑烷二酮环氧与CA II之间的两个氢键，3-未取代的2,4-恶唑烷二酮与CA II结合。蛋白质骨架。此外，3-未取代的2

  DOI：

  10.1021/acs.jmedchem.7b00606

文献信息

• NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR
  申请人：Chung Hae Young

  公开号：US20140023603A1

  公开（公告）日：2014-01-23

  Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.

  提供了一种具有美白皮肤、抗氧化和PPAR活性的新化合物及其医疗用途，该化合物具有美白皮肤的活性，可抑制酪氨酸酶，因此适用于用于美白皮肤的药物组合物或化妆品；具有抗氧化活性，因此适用于预防和治疗皮肤老化；具有PPAR活性，特别是PPARα和PPARγ活性，因此适用于用于预防和治疗肥胖、代谢性疾病或心血管疾病的药物组合物或保健食品。
• A solvent-free protocol for the green synthesis of arylalkylidene rhodanines in a task-specific ionic liquid
  作者：Abdolhamid Alizadeh、Mohammad M. Khodaei、Ali Eshghi

  DOI：10.1139/v10-011

  日期：2010.6

  2-Hydroxyethylammonium formate acts as a task-specific ionic liquid (TSIL) for the Knoevenagel condensation of carbonyl compounds with rhodanine to afford arylalkylidene rhodanines under solvent-free conditions and in good-to-excellent yields. Additionally, compared with those in organic solvents, the yields obtained in the presence of our ionic liquid (IL) were significantly increased. The detailed mechanism of the catalytic effect of TSIL is also reported for the first time.

  2-Hydroxyethylammonium formate 作为一种任务特异性离子液体 (TSIL)，可用于羰基化合物与罗丹宁的 Knoevenagel 缩合反应，从而在无溶剂条件下获得芳基亚烷基罗丹宁，而且收率极高。此外，与有机溶剂相比，在我们的离子液体（IL）存在下获得的产率显著提高。本研究还首次报道了 TSIL 催化作用的详细机理。
• NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF
  申请人：Pusan National University Industry-University Cooperation Foundation

  公开号：US20160102065A1

  公开（公告）日：2016-04-14

  Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.

  提供了一种具有美白、抗氧化和PPAR活性的新化合物及其医疗用途。该化合物具有抑制酪氨酸酶的美白活性，因此可用于美白药物组合物或化妆品产品；具有抗氧化活性，因此可用于预防和治疗皮肤老化；具有PPAR活性，特别是PPARα和PPARγ活性，因此可用于有效预防和治疗肥胖症、代谢疾病或心血管疾病的药物组合物或保健食品。
• Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease
  申请人：ELI LILLY AND COMPANY

  公开号：EP0587377A2

  公开（公告）日：1994-03-16

  Provided are methods for treating hyperglycemia and Alzheimer's disease utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant methods are novel and, accordingly, such compounds, process for preparing same and pharmaceutical formulations thereof, are also provided.

  本发明提供了利用某些罗丹宁衍生物治疗高血糖和阿尔茨海默病的方法。在本方法中使用的某些罗丹宁衍生物是新颖的，因此还提供了此类化合物、其制备工艺和药物制剂。
• Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
  申请人：ELI LILLY AND COMPANY

  公开号：EP0915090A1

  公开（公告）日：1999-05-12

  Provided are methods for treating hyperglycemia and Alzheimer's disease utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant methods are novel and, accordingly, such compounds, process for preparing same and pharmaceutical formulations thereof, are also provided.

  本发明提供了利用某些罗丹宁衍生物治疗高血糖和阿尔茨海默病的方法。在本方法中使用的某些罗丹宁衍生物是新颖的，因此还提供了此类化合物、其制备工艺和药物制剂。